Finafloxacin

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Efficacy and Safety of Finafloxacin Otic Suspension, 0.3% for the Treatment of Acute Otitis Externa: Results from two Phase III Randomized Clinical Studies.

Efficacy and Safety of Finafloxacin Otic Suspension, 0.3% for the Treatment of Acute Otitis Externa: Results from two Phase III Randomized Clinical Studies.

Journal: The Annals of otology, rhinology, and laryngology

Published: May 29, 2026

An evaluation of antibiotic options for the treatment of biothreat pathogens.

An evaluation of antibiotic options for the treatment of biothreat pathogens.

Journal: Frontiers in antibiotics

Published: April 14, 2025

Layering vaccination with antibiotic therapy results in protection and clearance of Burkholderia pseudomallei in Balb/c mice.

Layering vaccination with antibiotic therapy results in protection and clearance of Burkholderia pseudomallei in Balb/c mice.

Journal: Infection and immunity

Published: January 30, 2024

Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China.

Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China.

Journal: Heliyon

Published: June 23, 2023

In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens.

In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens.

Journal: Antibiotics (Basel, Switzerland)

Published: April 03, 2023

Antibiotic discovery against Piscirickettsia salmonis using a combined in silico and in vitro approach.

Antibiotic discovery against Piscirickettsia salmonis using a combined in silico and in vitro approach.

Journal: Microbial pathogenesis

Published: January 28, 2023

Clinical efficacy and safety of novel antibiotics for complicated urinary tract infection: A systematic review and meta-analysis of randomized controlled trials.

Clinical efficacy and safety of novel antibiotics for complicated urinary tract infection: A systematic review and meta-analysis of randomized controlled trials.

Journal: International journal of antimicrobial agents

Published: November 07, 2022

Efficacy of finafloxacin in a murine model of inhalational glanders.

Efficacy of finafloxacin in a murine model of inhalational glanders.

Journal: Frontiers in microbiology

Published: September 29, 2022

An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational Burkholderia pseudomallei.

An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational Burkholderia pseudomallei.

Journal: Antibiotics (Basel, Switzerland)

Published: September 16, 2022

In Vitro Activity of Delafloxacin and Finafloxacin against Mycoplasma hominis and Ureaplasma Species.

In Vitro Activity of Delafloxacin and Finafloxacin against Mycoplasma hominis and Ureaplasma Species.

Journal: Microbiology spectrum

Published: May 09, 2022

Investigation of a combination therapy approach for the treatment of melioidosis.

Investigation of a combination therapy approach for the treatment of melioidosis.

Journal: Frontiers in microbiology

Published: May 02, 2022

Potential new fluoroquinolone treatments for suspected bacterial keratitis.

Potential new fluoroquinolone treatments for suspected bacterial keratitis.

Journal: BMJ open ophthalmology

Published: February 19, 2022

Showing 1-12 of 50

Last Updated: 09/26/2026